Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) EBIT Margin (2016 - 2025)

Historic EBIT Margin for iBio (IBIO) over the last 17 years, with Q3 2025 value amounting to 5951.0%.

  • iBio's EBIT Margin changed N/A to 5951.0% in Q3 2025 from the same period last year, while for Dec 2025 it was 8491.0%, marking a year-over-year decrease of 43416700.0%. This contributed to the annual value of 4650.5% for FY2025, which is 27423900.0% up from last year.
  • iBio's EBIT Margin amounted to 5951.0% in Q3 2025.
  • In the past 5 years, iBio's EBIT Margin registered a high of 377.11% during Q1 2022, and its lowest value of 10206.0% during Q3 2023.
  • Its 5-year average for EBIT Margin is 3597.2%, with a median of 2209.5% in 2024.
  • The largest annual percentage gain for iBio's EBIT Margin in the last 5 years was 32917600bps (2021), contrasted with its biggest fall of -45314600bps (2021).
  • iBio's EBIT Margin (Quarter) stood at 6220.24% in 2021, then soared by 94bps to 377.11% in 2022, then crashed by -2606bps to 10206.0% in 2023, then surged by 78bps to 2209.5% in 2024, then plummeted by -169bps to 5951.0% in 2025.
  • Its last three reported values are 5951.0% in Q3 2025, 2599.0% for Q2 2025, and 2209.5% during Q4 2024.